AI Article Synopsis

  • Mitogen-activated extracellular signal-regulated kinase inhibitors (MEKi), like trametinib, show potential as a treatment for pediatric patients with low-grade gliomas, a type of brain tumor linked to abnormal MAP kinase pathway signaling.
  • There is limited knowledge about the long-term effectiveness and side effects of these therapies specifically for children.
  • The article discusses a unique case involving a young patient with a low-grade glioma who developed a rare skin infection caused by Mycobacterium chelonae while being treated with trametinib.

Article Abstract

Mitogen-activated extracellular signal-regulated kinase inhibitors (MEKi) represent a promising new therapy for pediatric patients with low-grade gliomas, which frequently have abnormal signaling within the mitogen-activated protein kinase (MAP kinase) pathway. However, understanding of long-term efficacy and toxicity is limited in pediatric glioma patients. This article describes a rare presentation of a widespread cutaneous infection with Mycobacterium chelonae in a pediatric patient with a low-grade glioma treated with trametinib.

Download full-text PDF

Source
http://dx.doi.org/10.1111/pde.15718DOI Listing

Publication Analysis

Top Keywords

cutaneous infection
8
infection mycobacterium
8
mycobacterium chelonae
8
chelonae pediatric
8
pediatric patient
8
treated trametinib
8
rare cutaneous
4
pediatric
4
patient treated
4
trametinib kras-mutated
4

Similar Publications

is a ubiquitous organism classified as a nontuberculous mycobacterium that rarely causes indolent skin or soft-tissue infections, especially in immunocompromised patients. Given the rarity of infection, diagnosis can be difficult because cutaneous lesions may be considered a worsening of the underlying disease or a benign condition. Here, we report a case of a rapidly progressing cutaneous infection in a patient with nephrotic syndrome.

View Article and Find Full Text PDF

Idiopathic Hypereosinophilic Syndrome With Cutaneous Manifestations: A Case Report.

Cureus

December 2024

Internal Medicine, Unidade Local De Saúde De São João, Porto, PRT.

Hypereosinophilic syndrome (HES) is marked by eosinophilic infiltration and the release of inflammatory mediators that cause damage to multiple organs. Despite careful evaluation of hypereosinophilia, the etiology of most cases remains undefined. Eosinophils may cause damage in almost all organs, and most patients present with dermatological manifestations.

View Article and Find Full Text PDF

Bloodstream infection in neonates is a complicated disease and presents a major challenge both in diagnosis and in therapeutic intervention. The focus of the present study was to investigate the incidence, the species distribution and the risk factors associated with mortality of bloodstream infections in a neonatal intensive care unit (NICU) and evaluating the antifungal susceptibility of traditional antifungal drugs and three nanoparticle-based drug delivery systems based on nanoparticles. A total of 458 patients were evaluated, and 9.

View Article and Find Full Text PDF

Layşmanyaz, yaklaşık 90'dan fazla ülke ve bölgeden bildirilen, ciddi ve endemik bir bulaşıcı hastalıktır. Kutanöz layşmanyaz (KL) ise vücudun açıkta kalan bölgelerinde oluşan, başlıca semptomları arasında vektör Phlebotomus ısırığından altı ay sonra kronikleşebilen veya kendiliğinden iyileşebilen ciltte tek, birden fazla ülserli veya nodüler lezyonlar bulunan, ölümcül olmayan ancak kalıcı izler bırakabilen bir hastalıktır. Klasik tedavi yöntemleri, uygulamada zorluk, direnç gelişimi ve yan etki gibi bir dizi soruna neden olmaktadır.

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a chronic and inflammatory skin disorder characterized by impaired barrier function and imbalanced immunity. Recent advances have revealed that dysbiosis of skin microbiota plays important roles in the pathogenesis and development of AD. Meanwhile, endogenous and external factors contribute to the dysbiosis of skin microbiota in AD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!